The mechanistic target of rapamycin complex 1 (mTORC1) has been found to be a key checkpoint in the pathogenesis of SREBP-1c mediated DNL and MASLD (Lee et al., 2017; Kim and Guan, 2019). The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.